The effects of collapsing factors on F-actin content and microtubule distribution of Helisoma growth cones.
Growth cone collapsing factors induce growth cone collapse or repulsive growth cone turning by interacting with membrane receptors that induce alterations in the growth cone cytoskeleton. A common change induced by collapsing factors in the cytoskeleton of the peripheral domain, the thin lamellopodial area of growth cones, is a decline in the number of radially aligned F-actin bundles that form the core of filopodia. The present study examined whether ML-7, a myosin light chain kinase inhibitor, serotonin, a neurotransmitter and TPA, an activator of protein kinase C, which induce growth cone collapse of Helisoma growth cones, depolymerized or debundled F-actin. We report that these collapsing factors had different effects. ML-7 induced F-actin reorganization consistent with debundling whereas serotonin and TPA predominately depolymerized and possibly debundled F-actin. Additionally, these collapsing factors induced the formation of a dense actin-ring around the central domain, the thicker proximal area of growth cones [Zhou and Cohan, 2001: J. Cell Biol. 153:1071-1083]. The formation of the actin-ring occurred subsequent to the loss of actin bundles. The ML-7-induced actin-ring was found to inhibit microtubule extension into the P-domain. Thus, ML-7, serotonin, and TPA induce growth cone collapse associated with a decline in radially aligned F-actin bundles through at least two mechanisms involving debundling of actin filaments and/or actin depolymerization.
Torreano
Paul J
PJ
Division of Anatomy and Cell Biology, University at Buffalo School of Medicine, Buffalo, NY 14214, USA.
Waterman-Storer
Clare M
CM
Cohan
Christopher S
CS
D000199:Actins / Q000187:drug effects* / Q000378:metabolism*; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D002478:Cells, Cultured; D003850:Deoxyribonuclease I / Q000378:metabolism; D020439:Growth Cones / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D008870:Microtubules / Q000187:drug effects* / Q000648:ultrastructure; D009281:Naphthalenes / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000648:ultrastructure; D010590:Phalloidine; D040121:Semaphorin-3A / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology; D012908:Snails; D013194:Staining and Labeling; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000199:Actins; D001381:Azepines; D009281:Naphthalenes; D040121:Semaphorin-3A; C070571:ML 7; D010590:Phalloidine; D012701:Serotonin; D003850:Deoxyribonuclease I; D013755:Tetradecanoylphorbol Acetate